Barclays PLC Atai Life Sciences N.V. Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Barclays PLC holds 245,717 shares of ATAI stock, worth $385,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245,717
Previous 245,717
-0.0%
Holding current value
$385,775
Previous $346,000
39.88%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ATAI
# of Institutions
96Shares Held
13.1MCall Options Held
229KPut Options Held
114K-
Morgan Stanley New York, NY2.67MShares$4.19 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.22MShares$3.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.4MShares$2.2 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0794KShares$1.25 Million0.0% of portfolio
-
Brown University719KShares$1.13 Million0.61% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $260M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...